Viewing Study NCT06778967


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-27 @ 9:33 AM
Study NCT ID: NCT06778967
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-25
First Post: 2025-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
Sponsor: Gan & Lee Pharmaceuticals.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-02-13
Start Date Type: ACTUAL
Primary Completion Date: 2026-12-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-11
Completion Date Type: ESTIMATED
First Submit Date: 2025-01-03
First Submit QC Date: None
Study First Post Date: 2025-01-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-20
Last Update Post Date: 2025-11-25
Last Update Post Date Type: ESTIMATED